Biological determinism and the stage-dependent role of surgical approach in gallbladder cancer: A 20-year cohort study and meta-analysis.

Eur J Surg OncolAug 31, 2026 (epub)

Yan-Yu Qiu, Sen Yang, Meng-Qing Sun et al.

✦ AI-curated · Sources linked

In 30 seconds

This retrospective cohort study of 416 patients who underwent gallbladder cancer surgery at a national tertiary centre from 2003 to 2022, combined with a systematic review and meta-analysis of surgical approach in incidental gallbladder cancer (IGBC), examined survival determinants and operative strategy. Most cohort patients had stage III–IV disease (68%), and 44.0% had an R0 resection. Tumour biology strongly shaped prognosis; R0 resection was associated with better overall and disease-free survival (HR 0.27 and 0.23, respectively). The meta-analysis found a stage-dependent survival benefit for primary laparoscopy in IGBC, particularly for T2 tumours.

Key findings

  • The cohort had an R0 resection rate of 44.0%; perioperative morbidity was 12.7% and 30-day mortality was 0.7%.
  • IGBC was associated with lower recurrence than conventional GBC (20.0% vs. 34.7%, P = 0.044) and longer median OS (56.5 vs. 32.0 months).
  • R0 resection was associated with improved OS (HR 0.27) and DFS (HR 0.23) in multivariable analysis.
  • Meta-analysis found a stage-dependent survival benefit for primary laparoscopic surgery in IGBC, particularly for T2 tumours.

Why it matters

The findings underscore the challenge of treating a cancer commonly diagnosed at advanced stages and the importance of complete oncologic resection when feasible. They also suggest that surgical approach may matter differently by stage in incidental disease, supporting careful selection rather than assuming one approach is optimal for all patients.

What to keep in mind

The cohort was retrospective and drawn from a single national tertiary centre; the abstract does not report the meta-analysis size or pooled effect estimate.

Source

Published in Eur J Surg Oncol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.